ClinicalTrials.Veeva

Menu

A New 360° Dual-task Based Protocol for the Pre-clinical In-hospital and At-home Rehabilitation of Elderly: DUAL-Rehab

I

Istituto Auxologico Italiano

Status

Enrolling

Conditions

Cognitive Decline

Treatments

Device: 360° media
Other: In hospital sessions
Other: Mild Cognitive Impairment
Other: at home sessions
Other: Treatment As Usual (TAU)
Other: Subjective Memory Complain

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The main objective of this project is two-fold

  1. to develop a Dual-Task training exploiting the potentiality of the 360° technology in terms of interactivity and ecological validity
  2. to investigate its efficacy in improving the cognitive functioning in a randomized clinical trial for 2 different populations: subjects with subjective memory complaints and mild cognitive impairment.

Specifically, participants will follow an integrated training including 2 phases: 1)in-hospital rehabilitation, where subjects will be provided sessions of the training in immersive modality; 2)at-home rehabilitation, where older adults will be asked to perform at home the non-immersive version of the training using a tablet.

Expected outcome is an improvement in cognitive functioning (assessed with a complete neuropsychological battery) after the training, thus advancing literature about non-pharmacological interventions in the preclinical stages of dementia along with innovative technical instruments.

Enrollment

90 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (group of SMC):

  • > 65 years old
  • self-reported memory complaints
  • score on Mini-Mental State Examination greater than or equal to 27/30 (normal range)

Exclusion Criteria:

  • no evidence of objective impairments on the neuropsychological testing, scores on the Clinical Dementia Rating < 0.5

Inclusion Criteria (group of MCI):

  • > 65 years old
  • a self-reported (or reported by a caregiver) cognitive decline
  • an objective impairment on the neuropsychological testing
  • scores on the Clinical Dementia Rating < 0.5.

Exclusion Criteria:

  • no dementia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

90 participants in 6 patient groups

360° media
Experimental group
Description:
All participants will be randomly assigned to 360° media or TAU condition
Treatment:
Device: 360° media
Treatment As Usual (TAU)
Active Comparator group
Description:
All participants will be randomly assigned to TAU or 360° media condition
Treatment:
Other: Treatment As Usual (TAU)
In hospital sessions
Other group
Description:
all participants will perform session in hospital
Treatment:
Other: In hospital sessions
at home sessions
Other group
Description:
all participants will perform session at home
Treatment:
Other: at home sessions
Mild Cognitive Impairment
Other group
Description:
half of the patients will have MCI
Treatment:
Other: Mild Cognitive Impairment
Subjective Memory Complain
Other group
Description:
half of the patients will have SMC
Treatment:
Other: Subjective Memory Complain

Trial contacts and locations

1

Loading...

Central trial contact

Elisa Pedroli, PsyD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems